Human heart endothelial-cell-restricted allorecognition

Transplantation

Volumn 62, Issue 3, 1996, Pages 403-406

  Jutte, Nicolet H P M ^a,c   Knoop, Christiaan J ^a   Heijse, Paula ^a   Balk, Aggie H M M ^a   Mochtar, Bas ^a   Claas, Frans H J ^b   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN;

ALLOIMMUNITY; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029824281     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608150-00017     Document Type: Article

References (15)

1. Paul LC, Carpenter CB. Antibodies against renal endothelial alloantigens. Transplant Proc 1980; 12 (suppl 1): 43.
2. Brasile L, Zerbe T, Rabin B, Clarke J, Abrams A, Cerilli J. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation 1985; 40: 672.
3. Hadley GA, Mohanakumar T. Kidney cell-restricted recognition of MHC class I alloantigens by human cytolytic T cell clones. Transplantation 1993; 55: 400.
4. Yard BA, Kooymans-Couthino M, Reterink T, et al. Analysis of T cell lines from rejecting renal allografts. Kidney Int 1993; 43 (suppl): S133.
5. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 586.
6. Balk AHMM, Simoons ML, Van de Linden MJMM, et al. Coronary artery disease after transplantation: timing of coronary arteriography. J Heart Lung Transplant 1993; 12: 89.
7. Jutte NHPM, Heijse P, van Batenburg MH, et al. Donor heart endothelial cells as targets for graft infiltrating lymphocytes after clinical cardiac transplantation. Transplant Immunol 1993; 1: 39.
8. Levine JE, Yang SY. SSOP typing of the tenth international histocompatibility workshop reference cell lines for HLA-C alleles. Tissue Antigens 1994; 44: 174.
9. Pardi R, Bender JR. Signal requirements for the generation of CD4+ and CD8+ T-cell responses to human allogeneic microvascular endothelium. Circ Res 1991; 69: 1269.
10. de Koster HS, Andersen DC, Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured autologous HLA-DR3 molecules by HLA-DP. J Exp Med 1989; 169: 1191.
11. Breur-Vriesendorp BS, Ivanyi P. Self-restricted primary human histocompatibility leukocyte antigen (HLA)-specific cytotoxic lymphocytes. Int Immunol 1993; 5: 103.
12. Vora M, Yssel H, DeVries JE, Karasek MA. Antigen presentation by human dermal microvascular endothelial cells: immunoregulatory effect of IFN-g and IL-10. J Immunol 1994; 152: 5734.
13. Heath WR, Sherman L. Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur J Immunol 1991; 21: 153.
14. Pointdexter NJ, Naziruddin B, McCourt DW, Mohanakumar T. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J Immunol 1995; 154: 3880.
15. Wu MX, Tsomides TJ, Eisen HN. Tissue distribution of natural peptides derived form a ubiquitous dehydrogenase, including a novel liver-specific peptide that demonstrates the pronounced specificity of low affinity T cell reactions. J Immunol 1995; 154: 4495.